Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Filings indexed 212 across all filing types
Latest filing 2021-03-19 Declaration of Voting R…
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend declarations, election of directors, and amendments to business purposes. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2021-03-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the share transactions (specifically a sale of 80 shares) by an executive (Yoon Deok-geun) of Il-Sung Pharmaceutical. This type of filing is a standard regulatory disclosure for insider trading/director dealings.
2021-03-17 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is titled '최대주주등소유주식변동신고서' (Report on Changes in Shareholding by Major Shareholders, etc.). It details specific share transactions (sales) by an executive/director (윤덕근) of the company (일성신약). This falls under the category of Director's Dealing (DIRS), which covers personal share transactions by company directors and executives.
2021-03-12 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Il-Sung Pharmaceuticals. It provides a summary table of financial data and audit opinions for the fiscal year 2020. According to the 'Menu vs Meal' rule, this is a notification of the submission of an audit report rather than the full audit report itself, and it fits the criteria for a Report Publication Announcement (RPA). FY 2020
2021-03-11 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 98% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Il-Sung Pharmaceutical Co., Ltd. for the fiscal year ending December 31, 2020. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis (MD&A) and business overview typically found in a full 10-K, and it is not an announcement (RPA) because it contains the full financial data and audit opinion. FY 2020
2021-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Il-Sung Pharmaceutical Co., Ltd. It contains the agenda for the 61st Annual General Meeting, including financial statement approval, director appointments, and proposed changes to the articles of incorporation. This document is a formal proxy statement/notice sent to shareholders to inform them of the meeting and solicit their votes. In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification, as it provides the necessary information for shareholders to exercise their voting rights at the upcoming meeting.
2021-03-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.